Tyngsboro, MA, United States of America

Robert B Nicewonger



 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Innovator Robert B. Nicewonger: A Pioneer in Pharmaceutical Research

Introduction

Robert B. Nicewonger, an accomplished inventor based in Tyngsboro, Massachusetts, holds an impressive portfolio of 11 patents. His contributions to the field of pharmaceutical research, particularly in the development of kinase inhibitors, have made significant strides in therapeutic advancements.

Latest Patents

Among Robert's latest patents are innovative compounds that function as aminopyrimidine kinase inhibitors. These compounds, along with their pharmaceutical compositions, are designed to modulate various pathways, including the casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), and the TGFβ, Wnt, JAK/STAT, and mTOR pathways. Such inventions are paramount for treating or preventing conditions linked to abnormal physiological activity within these pathways. Additionally, Robert has patented imidazole-2,4-dione inhibitors of casein kinase 1. Similar to his aminopyrimidine compounds, these inventions also target significant biological pathways and have potential therapeutic implications.

Career Highlights

Robert B. Nicewonger has worked with notable companies in the pharmaceutical sector, including Arqule, Inc. and Jasco Pharmaceuticals, LLC. His work at these organizations has provided him with invaluable experience and has propelled his research in the pharmaceutical industry. With a focus on proteins and pathways crucial to cellular function, Robert has pioneered methods that contribute to the understanding and treatment of various diseases.

Collaborations

Throughout his career, Robert has collaborated with talented professionals in the field, including colleagues such as Mark Anthony Ashwell and Jason Hill. Their collective expertise and teamwork have undoubtedly enriched the projects they undertook, advancing innovative solutions in pharmacology.

Conclusion

Robert B. Nicewonger exemplifies the spirit of innovation in the pharmaceutical industry through his substantial contributions and numerous patents. By focusing on critical biological pathways and developing targeted inhibitors, his work continues to influence therapeutic strategies and open doors for future research in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…